Net Neutrality Ruling Places These Stocks at Risk >>> READ MORE

Trade of the Day: Coherus Biosciences Inc (CHRS)

The broad market is weakening, and stocks like CHRS are particularly vulnerable

By Ken Trester, Editor, Maximum Options

http://bit.ly/2zbw2U4

To receive further updates on this Coherus Biosciences Inc (NASDAQ:CHRS) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of Power Options Weekly today

My indicators are giving strong bearish readings for the fifth week in a row now. Until Thursday’s rally, we had seen the market start to cascade lower over the past week or so, but there’s the potential for stocks to continue their decline again once the exuberance over the tax-reform bill getting through the House yesterday wears off.

If that bill is rejected by the Senate, however, it’s going to be a big negative for the market, and I wouldn’t be surprised to see a mild correction of 3% or more in that situation.

Over the last 20 months, the Dow Jones has increased about 40%, which translates to roughly 2% per month. This is very excessive and, while November has been relatively bearish, I think this continual grind higher is a warning sign that we may start to see some cracks in the rally.

As a result of the enormous appreciation we’ve witnessed, some of the top economists are saying that the market is overpriced. Robert Shiller, one of the economists who I respect a lot, stated this week that he is concerned that both individual and institutional investors have lost confidence in the valuation of the market.

I agree, and valuations are certainly stretched. So, today I’m recommending a bearish trade: puts on Coherus Biosciences Inc (NASDAQ:CHRS).

While generally speaking I like biotech, in a weakening market it’s a good idea to trade neglected and unloved names to the downside.

Buy to open the CHRS Jan (2018) 7.50 Put (CHRS180119P00007500) at $0.45 or lower.

Follow our Facebook page to receive each Trade of the Day direct to your News Feed — and join the conversation.

InvestorPlace advisor Ken Trester brings you Power Options Weekly, which delivers 5 new options trades and his latest trading advice to you each Friday. It’s the perfect ‘bridge’ between investing in ordinary stocks and the turbocharged world of options trading.

Trester has been trading options since the first exchanges opened in 1973 with a winning streak that goes back to 1984 with money-doubling average annual profits since 1990. Try Power Options Weekly today and receive 2 weeks for the price of 1 for only $19.95.


Article printed from InvestorPlace Media, https://investorplace.com/2017/11/trade-day-coherus-biosciences-inc-chrs/.

©2017 InvestorPlace Media, LLC